Long-Term Benefit for T+A in Live...

Long-Term Benefit for T+A in Liver Cancer confirmed with CHIEF data - Beyond the Trial

Liver Cancer Podcast por International Liver Cancer Association (ILCA)
T3 · E10
15 may 2026
17:12

Notas del episodio

Season 3 - Episode 10

In this episode, Dr. Manon Allaire, a physician at La Pitié-Salpêtrière Hospital in Paris, shares her perspective on evolving approaches in liver cancer care. Using the CHIEF data as a starting point, the discussion looks beyond the trial to reflect on how emerging evidence is interpreted in clinical practice. Dr. Allaire offers a thoughtful overview of key considerations, ongoing questions, and what these discussions may mean for the future of treatment.

Palabras clave

liver cancer
clinical trials
hcc
systemic therapy
cell biology
hepatocellular carcinoma